CVE-2025-61940
High
Description
NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.
SeverityHigh
CVSS8.3
Exploit probability—
ProductMirion Biodose\/nmis
PublishedDec 2, 2025
First seenDec 2, 2025
Weakness typeCWE-603CWE-603
How to fix
Update
- mirion biodose\/nmis23.0 or later
Affected products
| Product | Affected versions | Fixed in |
|---|---|---|
| mirion biodose\/nmis | v < 23.0 | 23.0 |
Check your version
Choose the product and enter the version you run to see whether it falls in the affected range.
In the Intelligence 360 plan
Attack Surface Management
See the assets tied to your domains, the technologies they run and known vulnerabilities in one list.